Qian-Ze Dong
Overview
Explore the profile of Qian-Ze Dong including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
430
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shi P, Li Y, Wang S, Sun R, Xu H, Dong Q, et al.
Appl Immunohistochem Mol Morphol
. 2019 Jan;
28(1):49-56.
PMID: 30601156
Background: The aim of this study was to compare epidermal growth factor receptor (EGFR) mutations between primary tumors and corresponding bone metastases (BMs) in lung adenocarcinoma. Materials And Methods: In...
2.
Liu N, Sun R, Du J, Dong Q, Fan C, Li Q, et al.
Appl Immunohistochem Mol Morphol
. 2017 Aug;
26(4):e44-e51.
PMID: 28800007
Background: Although the use of pleural effusion samples for epidermal growth factor receptor (EGFR) testing in lung cancer is increasing, the accuracy rate and effectiveness of identifying EGFR mutations using...
3.
Liu Y, Wang S, Dong Q, Liu N, Han Y, Zhang X, et al.
Appl Immunohistochem Mol Morphol
. 2016 Jun;
26(1):64-70.
PMID: 27299185
Background: Previous research connects p120-catenin (p120ctn) with epidermal growth factor receptor (EGFR) signaling pathways, which presents a potential role for p120ctn in EGFR tyrosine kinase inhibitor (EGFR-TKIs) resistance. However, a...
4.
Liu Y, Wang S, Dong Q, Jiang G, Han Y, Wang L, et al.
Med Oncol
. 2016 Jan;
33(3):22.
PMID: 26820570
Exploring methods for increasing epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) sensitivity has become a major focus in non-small cell lung cancer (NSCLC). Major downstream effectors of the Rho...
5.
Liu Y, Dong Q, Wang S, Xu H, Miao Y, Wang L, et al.
PLoS One
. 2014 Feb;
9(2):e87537.
PMID: 24498333
Background: We have reported that p120-catenin could regulate β-catenin transcription in lung cancer cells, but the specific mechanism is unclear. Methods And Results: In this study, bisulfite sequencing PCR showed...
6.
Liu Y, Dong Q, Wang S, Fang C, Miao Y, Wang L, et al.
BMC Cancer
. 2013 Jul;
13:346.
PMID: 23865714
Background: Pygopus 2 (Pygo2) is a Pygo family member and an important component of the Wnt signaling transcriptional complex. Despite this data, no clinical studies investigating Pygo2 expression in lung...
7.
Tang Z, Dong Q, Cui Q, Papavassiliou P, Wang E, Wang E
PLoS One
. 2013 Jun;
8(6):e63676.
PMID: 23776433
Previous studies suggested Ataxia-telangiectasia group D complementing gene (ATDC) as an oncogene in many types of cancer. However, its expression and biological functions in non-small cell lung cancer (NSCLC) remain...
8.
Cui Q, Tang Z, Zhang X, Zhao H, Dong Q, Xu K, et al.
J Histochem Cytochem
. 2013 Jun;
61(9):659-70.
PMID: 23761130
Leucine zipper tumor suppressor 2 (LZTS2) is implicated in several cancers; however, its biological mechanisms in non-small cell lung cancer (NSCLC) are not yet understood. We found that low levels...
9.
Tang Z, Cui Q, Dong Q, Xu K, Wang E
Tumour Biol
. 2013 May;
34(5):2835-42.
PMID: 23681803
Although the expression pattern and biological functions of ataxia-telangiectasia group D complementing gene (ATDC) had been implicated in several types of cancer, the roles and potential mechanisms of ATDC in...
10.
Dong Q, Wang Y, Tang Z, Fu L, Li Q, Wang E, et al.
Am J Pathol
. 2013 Jan;
182(3):954-64.
PMID: 23306155
Previous studies indicated a role of Derlin-1 in human cancers; however, its expression pattern in non-small cell lung cancer (NSCLC) and the molecular mechanism of Derlin-1 on cancer progression have...